Ondansetron Hydrochloride USP (Dihydrate) API For Compounding

Ondansetron USP (Dihydrate) is an active pharmaceutical ingredient (API) that is commonly used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. It belongs to a class of drugs known as serotonin 5-HT3 receptor antagonists and works by blocking the action of serotonin, a chemical in the body that can trigger nausea and vomiting. It is also sometimes used to prevent or treat nausea and vomiting associated with other medical procedures or conditions, such as severe and prolonged motion sickness. Additionally, ondansetron may be used to prevent postoperative nausea and vomiting. Overall, it helps to improve the quality of life for individuals undergoing treatment for cancer or other medical procedures that can cause nausea and vomiting.

Ondansetron Hydrochloride USP is a medication that is used for compounding medications. It is often used as an antiemetic (anti-nausea) medication for people who are experiencing nausea or vomiting due to chemotherapy, radiation therapy, or surgery. Ondansetron may also be used for other conditions such as nausea and vomiting caused by other drugs, as well as for the prevention of nausea and vomiting during pregnancy. When used for compounding, ondansetron can be mixed with other medications to create a customized blend that is tailored to the specific needs of the patient.

CAS Number: 103639-04-9

Property: Light Sensitive | Hazardous Material